RxDoctor Payments Data

William Delp, DO

Family Medicine · Monroe, GANPI 1225262579

Payments from drug & device makers

$8,003in general payments, 2019–2025

Across 504 payments — averaging $15.88 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$878
  • AstraZeneca$856
  • Novo Nordisk$806
  • Lilly USA, LLC$623
  • Amgen$616
  • Pfizer$440
  • plus $4K from 43 others

What the payments were for

  • Food & beverage$7,965100%
  • Education$380%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$8,003 in reported general payments places this provider in the 90th percentile of 3,111 family medicine providers in Georgia.

See all family medicine providers in Georgia

Medicare billing

Part B allowed, 2024
$78,627
Medicare patients
164
Services billed
1,054

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide77$99,115
MounjaroTirzepatide45$57,018
JardianceEmpagliflozin41$53,145
EliquisApixaban64$46,803
TrulicityDulaglutide23$46,777
JanuviaSitagliptin Phosphate24$23,490
FarxigaDapagliflozin Propanediol33$22,211
Tresiba Flextouch U-200Insulin Degludec28$21,623
XareltoRivaroxaban23$21,367
Xultophy 100-3.6Insulin Degludec/Liraglutide15$20,698
Trelegy ElliptaFluticasone/Umeclidin/Vilanter18$20,331
LinzessLinaclotide23$18,796
LatudaLurasidone Hcl12$16,007
Xigduo XrDapaglifloz Propaned/Metformin13$14,464
Soliqua 100-33Insulin Glargine/Lixisenatide13$13,976

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic, Xultophy 100-3.6$806$119,81392 claims
Lilly USA, LLCMounjaro, Trulicity$623$103,79568 claims
Boehringer IngelheimJardiance$124$53,14541 claims
PfizerEliquis$440$46,80364 claims
GSKTrelegy Ellipta, Breo Ellipta$309$27,63332 claims
MerckJanuvia$194$23,49024 claims
AstraZenecaFarxiga$856$22,21133 claims
Johnson & JohnsonXarelto$116$21,36723 claims
AbbVieLinzess$878$18,79623 claims
Sunovion Pharmaceuticals Inc.Latuda$20$16,00712 claims
Sanofi-aventis U.S. LLCSoliqua 100-33$110$13,97613 claims
Takeda Pharmaceuticals U.S.A., Inc.Motegrity, Vyvanse$172$10,02822 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 3,111 family medicine providers in Georgia.

Other family medicine in Monroe

See the full list for Georgia

Where these figures come from

Is this you, or does something look wrong? →